C. Chow (Toronto, ON, Canada), A. Bourdin (Montpellier Cédex 5, France), L. Toennesen (Copenhagen, Denmark)
Absolute lung size explains the sex difference in breathlessness in the general population M. Ekstrom (Lyckeby, Sweden)
| |
Quality of Life in Asthma Patients: A Nationwide Population-Based Study J. Chung (Incheon, Republic of Korea)
| |
New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) M. Latorre (Pisa, PI, Italy)
| |
Correlations between functional performance, health status and inflammatory biomarkers in stable COPD N. Saiphoklang (Pathumthani, Thailand)
| |
Inhaled corticosteroid (ICS) and long-acting beta2-agonist (LABA) combination vs. high doses of ICS: efficacy and safety in patients (pts) with uncontrolled occupational asthma K. Gashynova (Dniepropetrovsk, Ukraine)
| |
Regular exercise and asthma control in adults: A randomized controlled trial J. Jaakkola (Oulu, Finland)
| |
Chronic mucus hypersecretion in severe asthma E. Wedge (København, Denmark)
| |
Inhalation of hydrogen gas attenuate airway inflammation and oxidative stress in allergic asthmatic mice J. Zhang (Shanghai, China)
| |
The serum YKL-40 is a useful biomarker for asthma X. Tong (CHENGDU, China)
| |
Web-based self-management support after pulmonary rehabilitation of difficult to treat asthma: a randomised controlled trial J. Snoeck-Stroband (Leiden, Netherlands)
| |
Estimation of the hospitalization cost for asthma exacerbation in a pulmonology department B. Hamdi (Manouba oued ellil, Tunisia)
| |
Dysfunctional breathing in patients with severe asthma is associated with poor asthma control and low quality of life. F. Barati Sedeh (Birkerød, Denmark)
| |
Effect of treatment with tiotropium bromide 18 mcg on asthma control and asthma-related quality of life in patients with asthma-COPD overlap syndrome. K. Nazarenko (Kyiv, Ukraine)
| |
Adherence to ICS in pregnant with infectious exacerbations of asthma (IEA) N. Kravchenko (Dniepropetrovsk, Ukraine)
| |
Features of laboratory, functional and radiological parameters at ACOS S. Chubarova (Krasnoyarsk, Krasnoyarsk Krai, Russian Federation)
| |
Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study A. Gomez-Bastero (Sevilla, Spain)
| |
Effects of GABA on lung function in asthmatics after methacholine inhalation D. Dimic (Beograd, Republic of Serbia)
| |
Risk factors for hospitalization and ICU admission for near-fatal asthma> J. Juárez León (Mexico City, Mexico)
| |
Body composition in heart failure and chronic obstructive pulmonary disease patients A. NAVARRETE PEÑALOZA (mexico city, Mexico)
| |